SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-065631
Filing Date
2024-05-28
Accepted
2024-05-28 16:44:39
Documents
18
Period of Report
2024-07-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm243011d2_def14a.htm   iXBRL DEF 14A 1426464
6 GRAPHIC bc_netincome-4clr.jpg GRAPHIC 65174
7 GRAPHIC bc_tsr-4clr.jpg GRAPHIC 70617
8 GRAPHIC px_24precigenproxy1pg01-bwlr.jpg GRAPHIC 244010
9 GRAPHIC px_24precigenproxy1pg02-bwlr.jpg GRAPHIC 158947
  Complete submission text file 0001104659-24-065631.txt   3462607

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pgen-20231231.xsd EX-101.SCH 9728
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pgen-20231231_def.xml EX-101.DEF 5568
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pgen-20231231_lab.xml EX-101.LAB 34446
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pgen-20231231_pre.xml EX-101.PRE 4743
21 EXTRACTED XBRL INSTANCE DOCUMENT tm243011d2_def14a_htm.xml XML 126545
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36042 | Film No.: 24992654
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)